A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults - Aliprantis, Antonios O.; Shaw, Christine A.; Griffin, Paul; Farinola, Nicholas; Railkar, Radha A.; Cao, Xin; Liu, Wen; Sachs, Jeffrey R.; Swenson, Christine J.; Lee, Heather; Cox, Kara S.; Spellman, Daniel S.; et al. (Human vaccines & immunotherapeutics, 2021)
Keywords: prefusion F; Research Paper; Respiratory Syncytial Virus; RSV; vaccine; vaccine safety and immunogenicity; prefusion F; vaccine safety and immunogenicity; vaccine; Respiratory Syncytial Virus; RSV